Helen of Troy (HELE)
(Delayed Data from NSDQ)
$61.08 USD
-0.27 (-0.44%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $61.00 -0.08 (-0.13%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$61.08 USD
-0.27 (-0.44%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $61.00 -0.08 (-0.13%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth C Momentum B VGM
Zacks News
New Strong Sell Stocks for April 13th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Factors Setting the Tone for Rite Aid's (RAD) Q4 Earnings
by Zacks Equity Research
Rite Aid (RAD) is expected to have witnessed soft front-end sales in fourth-quarter fiscal 2020, due to restrictions on sale of tobacco in New York, and over-the-counter cough-cold and flu products.
Here's How Bed Bath & Beyond (BBBY) Looks Ahead of Q4 Earnings
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is likely to have witnessed a soft top line, lower gross margins and higher SG&A expense in fourth-quarter fiscal 2019, due to soft traffic trends and challenges in execution.
5 Consumer Staple Stocks for Your Easter Basket Amid Coronavirus
by Vrishali Bagree
Amid coronavirus-led jitters, we have picked five consumer staple stocks with solid growth prospects. These stocks carry a favorable Zacks Rank and have gained at least 15% in a year.
Things You Must Know Ahead of Lamb Weston's (LW) Q3 Earnings
by Zacks Equity Research
Strength in the Global segment is likely to get reflected in Lamb Weston's (LW) third-quarter fiscal 2020 performance. However, increased manufacturing and SG&A costs are concerns.
Things You Must Know Ahead of Conagra's (CAG) Q3 Earnings
by Zacks Equity Research
Conagra's (CAG) third-quarter fiscal 2020 results are likely to reflect weaker-than-anticipated category performance.
Here's All You Must Note Ahead of McCormick (MKC) Q1 Earnings
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2020 results are likely to reflect gains from innovation and savings from the CCI program. However, volatile currency movements are concerning.
Will Helen of Troy (HELE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Helen of Troy (HELE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Darling Ingredients, Malibu Boats, Helen of Troy and Gray Television
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Darling Ingredients, Malibu Boats, Helen of Troy and Gray Television
Lamb Weston Up More Than 35% in a Year on Solid Sales Trend
by Zacks Equity Research
Lamb Weston's (LW) focus on efficient buyouts and capacity-expansion efforts bode well. Further, the company is gaining from its LTO innovation.
4 Domestic Stocks to Shield Your Portfolio From Coronavirus
by Manaswita Ghosh Dutta
Stocks with domestic operations could be a safe bet as fears over the Chinese epidemic's impact on the global economy intensify.
Kraft Heinz (KHC) Q4 Earnings Surpass Estimates, Sales Lag
by Zacks Equity Research
Kraft Heinz's (KHC) fourth-quarter sales hurt by unfavourable currency and impacts of divestiture.
Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.
International Flavors' (IFF) Q4 Earnings & Sales Top Estimates
by Zacks Equity Research
International Flavors (IFF) registers high-single digit currency neutral sales growth and stellar double-digit adjusted EPS growth in Q4.
Bed Bath & Beyond Stock Tanks on Soft Q4 Performance Update
by Zacks Equity Research
Bed Bath & Beyond (BBBY) provides fourth-quarter fiscal 2019 performance update. The company is facing short-term headwinds in its efforts to stabilize the business.
Here's Why Procter & Gamble's a Promising Investment Option
by Zacks Equity Research
Procter & Gamble (PG) is gaining from its cost-saving plans, strong organic sales growth and efforts to improve productivity. Also, the company is on track to improve its product portfolio.
Here's Why Hershey (HSY) is an Attractive Pick for Investors
by Zacks Equity Research
Hershey (HSY) has been undertaking buyouts to augment portfolio and expand in the snacking category. Also, the company's focus on enhancing operating efficiency bodes well.
Helen of Troy (HELE) Up 3.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Estee Lauder (EL) Shares Rise on Q2 Earnings & Sales Beat
by Zacks Equity Research
Estee Lauder's (EL) second-quarter fiscal 2020 results reflect strength in Skin Care and Fragrance categories, Estee Lauder brand, travel retail and online channels.
5 Stocks Trading Near 52-Week High That Can Scale Higher
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Coty (COTY) Surpasses Earnings and Revenue Estimates in Q2
by Zacks Equity Research
Weak Consumer Beauty sales hurt Coty's (COTY) top line in second-quarter fiscal 2020.
Clorox (CLX) Beats Q2 Earnings & Sales Estimates, Stock Up
by Zacks Equity Research
Clorox (CLX) second-quarter fiscal 2020 results reflect increase in gross margin. This marks the fifth straight quarter of gross margin growth.
Church & Dwight (CHD) Q4 Earnings Meet Estimates, Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) Q4 sales improve on benefits from category growth and market share gains. However, earnings decline year over year.
Colgate (CL) Stock Up on Q4 Sales Beat, Earnings In Line
by Zacks Equity Research
Colgate (CL) beats fourth-quarter 2019 sales estimates on strong volume and pricing gains. The company outlines view for 2020.
Inter Parfums (IPAR) Posts Sales Numbers for Q4 & 2019
by Zacks Equity Research
Inter Parfums (IPAR) reports record high sales in 2019. However, strong dollar and relatively fewer launches are concerns.